Neurology

Discussing how performing EMG can contribute to improving the diagnostic time and success in differential diagnosis of myotonic disorders

The Latest Developments in MS Classification and Treatment: From AI to Clinical Decision Making, a BMS-promotional Symposium ECTRIMS 2023, presents a thought-provoking view on the latest developments in the field of Multiple Sclerosis. 𝗙𝗼𝗿 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗣𝗿𝗼𝗳𝗲𝘀𝘀𝗶𝗼𝗻𝗮𝗹𝘀 𝗼𝗻𝗹𝘆. 𝗧𝗵𝗶𝘀 𝘀𝘆𝗺𝗽𝗼𝘀𝗶𝘂𝗺 𝘄𝗮𝘀 𝗼𝗿𝗴𝗮𝗻𝗶𝘀𝗲𝗱 𝗮𝗻𝗱 𝗳𝘂𝗻𝗱𝗲𝗱 𝗯𝘆 𝗕𝗿𝗶𝘀𝘁𝗼𝗹 𝗠𝘆𝗲𝗿𝘀 𝗦𝗾𝘂𝗶𝗯𝗯. 𝗕𝗠𝗦 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀 𝗮𝗻𝗱/𝗼𝗿 𝗽𝗿𝗼𝗱𝘂𝗰𝘁 𝗶𝗻𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻 𝗺𝗮𝘆 𝗯𝗲 𝗱𝗶𝘀𝗰𝘂𝘀𝘀𝗲𝗱. IMM-GB-2300537 | Date of Prep: Jan 2024

EAN 2023: Cutting edge diagnosis and management strategies in neuromuscular disease. This highly informative and thought-provoking…

The Burden of Cognitive Impairment in MS, ECTRIMS 2022 BMS-sponsored Symposium, highlights the importance of early awareness of cognitive impairment (CI), the impact to activities of daily living in patients with MS, the association of CI with MRI alterations and brain atrophy. 𝗙𝗼𝗿 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗣𝗿𝗼𝗳𝗲𝘀𝘀𝗶𝗼𝗻𝗮𝗹𝘀 𝗼𝗻𝗹𝘆. 𝗧𝗵𝗶𝘀 𝘀𝘆𝗺𝗽𝗼𝘀𝗶𝘂𝗺 𝘄𝗮𝘀 𝗼𝗿𝗴𝗮𝗻𝗶𝘀𝗲𝗱 𝗮𝗻𝗱 𝗳𝘂𝗻𝗱𝗲𝗱 𝗯𝘆 𝗕𝗿𝗶𝘀𝘁𝗼𝗹 𝗠𝘆𝗲𝗿𝘀 𝗦𝗾𝘂𝗶𝗯𝗯. 𝗕𝗠𝗦 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀 𝗮𝗻𝗱/𝗼𝗿 𝗽𝗿𝗼𝗱𝘂𝗰𝘁 𝗶𝗻𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻 𝗺𝗮𝘆 𝗯𝗲 𝗱𝗶𝘀𝗰𝘂𝘀𝘀𝗲𝗱. 𝗜𝗠𝗠-𝗚𝗕-𝟮𝟯𝟬𝟬𝟯𝟵𝟬 𝗦𝗲𝗽𝘁 𝟮𝟯.

Brain Preservation and Cognition in MS, a BMS-promotional Symposium Charcot 2022, highlights new MRI biomarkers of brain atrophy, the importance of early intervention on cognitive outcomes in MS and the role of advanced therapies in MS. 𝗙𝗼𝗿 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗣𝗿𝗼𝗳𝗲𝘀𝘀𝗶𝗼𝗻𝗮𝗹𝘀 𝗼𝗻𝗹𝘆. 𝗧𝗵𝗶𝘀 𝘀𝘆𝗺𝗽𝗼𝘀𝗶𝘂𝗺 𝘄𝗮𝘀 𝗼𝗿𝗴𝗮𝗻𝗶𝘀𝗲𝗱 𝗮𝗻𝗱 𝗳𝘂𝗻𝗱𝗲𝗱 𝗯𝘆 𝗕𝗿𝗶𝘀𝘁𝗼𝗹 𝗠𝘆𝗲𝗿𝘀 𝗦𝗾𝘂𝗶𝗯𝗯. 𝗕𝗠𝗦 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀 𝗮𝗻𝗱/𝗼𝗿 𝗽𝗿𝗼𝗱𝘂𝗰𝘁 𝗶𝗻𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻 𝗺𝗮𝘆 𝗯𝗲 𝗱𝗶𝘀𝗰𝘂𝘀𝘀𝗲𝗱. 𝗜𝗠𝗠-𝗚𝗕-𝟮𝟯𝟬𝟬𝟯𝟵𝟬 𝗦𝗲𝗽𝘁 𝟮𝟯.

A real-life, severe case of AIP by Professor Jean-Charles Deybach, MD PhD. Video developed and funded by Alnylam Pharmaceuticals.

Experience the home of the European Academy of Neurology’s (EAN) annual congress 2018, in our behind the scenes look at this year’s Lisbon Congress…

Ondrej Lerch, MD from Charles University in Prague, 2nd Faculty of Medicine and Motol University Hospital, Prague, Czech Republic discusses a study…